348.5K XNAS Volume
XNAS 21 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Prante Gerhard | Director | Sale of securities on an exchange or to another person at price $ 1.92 per share. | 25 Feb 2025 | 1,150 | 7,707 (0%) | 0% | 1.9 | 2,208 | Class A Common Stock |
| Gerhard Prante | Director | Sale of securities on an exchange or to another person at price $ 2.07 per share. | 24 Feb 2025 | 1,150 | 8,857 (0%) | 0% | 2.1 | 2,381 | Class A Common Stock |
| Gerhard Prante | Director | Sale of securities on an exchange or to another person at price $ 2.20 per share. | 21 Feb 2025 | 1,150 | 10,007 (0%) | 0% | 2.2 | 2,530 | Class A Common Stock |
| Gerhard Prante | Director | Sale of securities on an exchange or to another person at price $ 2.35 per share. | 20 Feb 2025 | 1,150 | 11,157 (0%) | 0% | 2.4 | 2,703 | Class A Common Stock |
| Gerhard Prante | Director | Sale of securities on an exchange or to another person at price $ 2.58 per share. | 19 Feb 2025 | 1,150 | 12,307 (0%) | 0% | 2.6 | 2,967 | Class A Common Stock |
| Gerhard Prante | Director | Sale of securities on an exchange or to another person at price $ 2.52 per share. | 18 Feb 2025 | 1,150 | 14,607 (0%) | 0% | 2.5 | 2,898 | Class A Common Stock |
| Gerhard Prante | Director | Sale of securities on an exchange or to another person at price $ 2.52 per share. | 18 Feb 2025 | 1,150 | 13,457 (0%) | 0% | 2.5 | 2,898 | Class A Common Stock |
| Gerhard Prante | Director | Sale of securities on an exchange or to another person at price $ 2.60 per share. | 14 Feb 2025 | 1,150 | 15,757 (0%) | 0% | 2.6 | 2,990 | Class A Common Stock |
| Gerhard Prante | Director | Sale of securities on an exchange or to another person at price $ 2.53 per share. | 13 Feb 2025 | 1,150 | 16,907 (0%) | 0% | 2.5 | 2,910 | Class A Common Stock |
| Gerhard Prante | Director | Sale of securities on an exchange or to another person at price $ 2.45 per share. | 12 Feb 2025 | 1,150 | 18,057 (0%) | 0% | 2.5 | 2,818 | Class A Common Stock |
| Gerhard Prante | Director | Sale of securities on an exchange or to another person at price $ 2.48 per share. | 11 Feb 2025 | 1,150 | 19,207 (0%) | 0% | 2.5 | 2,852 | Class A Common Stock |
| Gerhard Prante | Director | Sale of securities on an exchange or to another person at price $ 2.52 per share. | 10 Feb 2025 | 1,150 | 20,357 (0%) | 0% | 2.5 | 2,898 | Class A Common Stock |
| Gerhard Prante | Director | Sale of securities on an exchange or to another person at price $ 2.50 per share. | 07 Feb 2025 | 1,150 | 21,507 (0%) | 0% | 2.5 | 2,875 | Class A Common Stock |
| Gerhard Prante | Director | Sale of securities on an exchange or to another person at price $ 2.55 per share. | 06 Feb 2025 | 1,150 | 22,657 (0%) | 0% | 2.6 | 2,933 | Class A Common Stock |
| Gerhard Prante | Director | Sale of securities on an exchange or to another person at price $ 2.52 per share. | 05 Feb 2025 | 1,150 | 23,807 (0%) | 0% | 2.5 | 2,898 | Class A Common Stock |
| Gerhard Prante | Director | Sale of securities on an exchange or to another person at price $ 2.45 per share. | 04 Feb 2025 | 1,150 | 24,957 (0%) | 0% | 2.5 | 2,818 | Class A Common Stock |
| Gerhard Prante | Director | Sale of securities on an exchange or to another person at price $ 2.41 per share. | 03 Feb 2025 | 1,150 | 26,107 (0%) | 0% | 2.4 | 2,772 | Class A Common Stock |
| Gerhard Prante | Director | Sale of securities on an exchange or to another person at price $ 2.55 per share. | 31 Jan 2025 | 1,150 | 27,257 (0%) | 0% | 2.6 | 2,933 | Class A Common Stock |
| Gerhard Prante | Director | Sale of securities on an exchange or to another person at price $ 2.46 per share. | 30 Jan 2025 | 1,150 | 28,407 (0%) | 0% | 2.5 | 2,829 | Class A Common Stock |
| Gerhard Prante | Director | Sale of securities on an exchange or to another person at price $ 2.42 per share. | 29 Jan 2025 | 1,150 | 29,557 (0%) | 0% | 2.4 | 2,783 | Class A Common Stock |
| Gerhard Prante | Director | Sale of securities on an exchange or to another person at price $ 2.44 per share. | 28 Jan 2025 | 1,150 | 30,707 (0%) | 0% | 2.4 | 2,806 | Class A Common Stock |
| Gerhard Prante | Director | Sale of securities on an exchange or to another person at price $ 2.37 per share. | 27 Jan 2025 | 1,150 | 31,857 (0%) | 0% | 2.4 | 2,726 | Class A Common Stock |
| Gerhard Prante | Director | Sale of securities on an exchange or to another person at price $ 2.60 per share. | 24 Jan 2025 | 1,150 | 33,007 (0%) | 0% | 2.6 | 2,990 | Class A Common Stock |
| Gerhard Prante | Director | Sale of securities on an exchange or to another person at price $ 2.59 per share. | 23 Jan 2025 | 1,150 | 34,157 (0%) | 0% | 2.6 | 2,979 | Class A Common Stock |
| Gerhard Prante | Director | Sale of securities on an exchange or to another person at price $ 2.50 per share. | 21 Jan 2025 | 1,150 | 37,607 (0%) | 0% | 2.5 | 2,875 | Class A Common Stock |
| Rory B. Riggs | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 4,000,000 | 4,000,000 | - | - | Pre-Funded Warrant | |
| Rory B. Riggs | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 4,000,000 | 4,000,000 | - | - | Common Warrant | |
| Gerhard Prante | Director | Sale of securities on an exchange or to another person at price $ 2.31 per share. | 21 Jan 2025 | 1,150 | 35,307 (0%) | 0% | 2.3 | 2,657 | Class A Common Stock |
| Gerhard Prante | Director | Sale of securities on an exchange or to another person at price $ 2.50 per share. | 21 Jan 2025 | 1,150 | 36,457 (0%) | 0% | 2.5 | 2,875 | Class A Common Stock |
| Gerhard Prante | Director | Sale of securities on an exchange or to another person at price $ 2.50 per share. | 17 Jan 2025 | 1,150 | 38,757 (0%) | 0% | 2.5 | 2,875 | Class A Common Stock |
| Gerhard Prante | Director | Sale of securities on an exchange or to another person at price $ 2.75 per share. | 15 Jan 2025 | 1,150 | 39,907 (0%) | 0% | 2.8 | 3,163 | Class A Common Stock |
| Gerhard Prante | Director | Sale of securities on an exchange or to another person at price $ 2.56 per share. | 15 Jan 2025 | 1,150 | 41,057 (0%) | 0% | 2.6 | 2,944 | Class A Common Stock |
| Gerhard Prante | Director | Sale of securities on an exchange or to another person at price $ 2.42 per share. | 14 Jan 2025 | 1,150 | 42,207 (0%) | 0% | 2.4 | 2,783 | Class A Common Stock |
| Gerhard Prante | Director | Sale of securities on an exchange or to another person at price $ 2.34 per share. | 13 Jan 2025 | 1,150 | 43,357 (0%) | 0% | 2.3 | 2,691 | Class A Common Stock |
| Gerhard Prante | Director | Sale of securities on an exchange or to another person at price $ 2.57 per share. | 10 Jan 2025 | 1,150 | 45,657 (0%) | 0% | 2.6 | 2,956 | Class A Common Stock |
| Gerhard Prante | Director | Sale of securities on an exchange or to another person at price $ 2.57 per share. | 10 Jan 2025 | 1,150 | 44,507 (0%) | 0% | 2.6 | 2,956 | Class A Common Stock |
| Gerhard Prante | Director | Sale of securities on an exchange or to another person at price $ 2.80 per share. | 08 Jan 2025 | 1,150 | 46,807 (0%) | 0% | 2.8 | 3,220 | Class A Common Stock |
| Gerhard Prante | Director | Sale of securities on an exchange or to another person at price $ 3.06 per share. | 07 Jan 2025 | 1,150 | 47,957 (0%) | 0% | 3.1 | 3,519 | Class A Common Stock |
| Gerhard Prante | Director | Sale of securities on an exchange or to another person at price $ 2.89 per share. | 03 Jan 2025 | 1,150 | 50,257 (0%) | 0% | 2.9 | 3,324 | Class A Common Stock |
| Gerhard Prante | Director | Sale of securities on an exchange or to another person at price $ 3.14 per share. | 03 Jan 2025 | 1,150 | 49,107 (0%) | 0% | 3.1 | 3,611 | Class A Common Stock |
| Rory B. Riggs | Director, Chief Executive Officer, Ten Percent Owner | 31 Dec 2024 | 1,388,084 | 0 | - | - | Class B Common Stock | ||
| Rory B. Riggs | Director, Chief Executive Officer, Ten Percent Owner | 31 Dec 2024 | 1,388,084 | 0 | - | - | Cibus Common Unit | ||
| Rory B. Riggs | Director, Chief Executive Officer, Ten Percent Owner | 31 Dec 2024 | 1,388,084 | 4,839,912 (14%) | 4% | - | Class A Common Stock | ||
| Peter Beetham | Director, President and CEO | 31 Dec 2024 | 3,503 | 382,437 (1%) | 0% | - | Class A Common Stock | ||
| Peter Beetham | Director, President and CEO | 31 Dec 2024 | 3,503 | 0 | - | - | Cibus Common Unit | ||
| Peter Beetham | Director, President and CEO | 31 Dec 2024 | 3,503 | 0 | - | - | Class B Common Stock | ||
| Prante Gerhard | Director | Sale of securities on an exchange or to another person at price $ 3.45 per share. | 19 Dec 2024 | 1,150 | 51,407 (0%) | 0% | 3.5 | 3,968 | Class A Common Stock |
| Gerhard Prante | Director | Sale of securities on an exchange or to another person at price $ 3.75 per share. | 18 Dec 2024 | 1,150 | 52,557 (0%) | 0% | 3.8 | 4,313 | Class A Common Stock |
| Gerhard Prante | Director | Sale of securities on an exchange or to another person at price $ 4.06 per share. | 16 Dec 2024 | 1,150 | 54,857 (0%) | 0% | 4.1 | 4,669 | Class A Common Stock |
| Prante Gerhard | Director | Sale of securities on an exchange or to another person at price $ 3.85 per share. | 16 Dec 2024 | 1,150 | 53,707 (0%) | 0% | 3.9 | 4,428 | Class A Common Stock |
| Gerhard Prante | Director | Sale of securities on an exchange or to another person at price $ 3.87 per share. | 13 Dec 2024 | 1,150 | 56,007 (0%) | 0% | 3.9 | 4,451 | Class A Common Stock |
| Gerhard Prante | Director | Sale of securities on an exchange or to another person at price $ 4.08 per share. | 12 Dec 2024 | 1,150 | 57,157 (0%) | 0% | 4.1 | 4,692 | Class A Common Stock |
| Gerhard Prante | Director | Sale of securities on an exchange or to another person at price $ 4.35 per share. | 11 Dec 2024 | 1,150 | 58,307 (0%) | 0% | 4.4 | 5,003 | Class A Common Stock |
| Gerhard Prante | Director | Sale of securities on an exchange or to another person at price $ 4.43 per share. | 10 Dec 2024 | 1,150 | 59,457 (0%) | 0% | 4.4 | 5,095 | Class A Common Stock |
| Gerhard Prante | Director | Sale of securities on an exchange or to another person at price $ 4.15 per share. | 09 Dec 2024 | 1,150 | 60,607 (0%) | 0% | 4.2 | 4,773 | Class A Common Stock |
| Gerhard Prante | Director | Sale of securities on an exchange or to another person at price $ 3.86 per share. | 06 Dec 2024 | 1,150 | 61,757 (0%) | 0% | 3.9 | 4,439 | Class A Common Stock |
| Gerhard Prante | Director | Sale of securities on an exchange or to another person at price $ 4.00 per share. | 05 Dec 2024 | 1,150 | 62,907 (0%) | 0% | 4 | 4,600 | Class A Common Stock |
| Gerhard Prante | Director | Sale of securities on an exchange or to another person at price $ 4.39 per share. | 04 Dec 2024 | 1,150 | 64,057 (0%) | 0% | 4.4 | 5,049 | Class A Common Stock |
| Gerhard Prante | Director | Sale of securities on an exchange or to another person at price $ 4.69 per share. | 03 Dec 2024 | 1,150 | 65,207 (0%) | 0% | 4.7 | 5,394 | Class A Common Stock |
| Gerhard Prante | Director | Sale of securities on an exchange or to another person at price $ 4.46 per share. | 02 Dec 2024 | 2,300 | 66,357 (0%) | 0% | 4.5 | 10,258 | Class A Common Stock |
| Gerhard Prante | Director | Sale of securities on an exchange or to another person at price $ 4.50 per share. | 27 Nov 2024 | 1,150 | 68,657 (0%) | 0% | 4.5 | 5,175 | Class A Common Stock |
| Gerhard Prante | Director | Sale of securities on an exchange or to another person at price $ 4.57 per share. | 26 Nov 2024 | 1,150 | 69,807 (0%) | 0% | 4.6 | 5,256 | Class A Common Stock |
| Gerhard Prante | Director | Sale of securities on an exchange or to another person at price $ 4.19 per share. | 25 Nov 2024 | 1,150 | 70,957 (0%) | 0% | 4.2 | 4,819 | Class A Common Stock |
| Gerhard Prante | Director | Sale of securities on an exchange or to another person at price $ 4.32 per share. | 22 Nov 2024 | 1,150 | 72,107 (0%) | 0% | 4.3 | 4,968 | Class A Common Stock |
| Gerhard Prante | Director | Sale of securities on an exchange or to another person at price $ 4.03 per share. | 20 Nov 2024 | 1,150 | 73,257 (0%) | 0% | 4.0 | 4,635 | Class A Common Stock |
| Gerhard Prante | Director | Sale of securities on an exchange or to another person at price $ 4.30 per share. | 20 Nov 2024 | 1,150 | 74,407 (0%) | 0% | 4.3 | 4,945 | Class A Common Stock |
| August J. Moretti | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2024 | 14,733 | 14,733 | - | - | Stock Option (Right-to-Buy) | |
| Gerhard Prante | Director | Sale of securities on an exchange or to another person at price $ 4.12 per share. | 18 Nov 2024 | 1,150 | 75,557 (0%) | 0% | 4.1 | 4,738 | Class A Common Stock |
| Gerhard Prante | Director | Sale of securities on an exchange or to another person at price $ 4.53 per share. | 18 Nov 2024 | 1,150 | 76,707 (0%) | 0% | 4.5 | 5,210 | Class A Common Stock |
| Carlo Broos | Interim CFO | Sale of securities on an exchange or to another person at price $ 5.30 per share. | 11 Nov 2024 | 4,647 | 74,197 (0%) | 0% | 5.3 | 24,629 | Common Stock |
| Carlo Broos | Interim CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2024 | 41,000 | 41,000 | - | - | Stock Option (Right-to-Buy) | |
| Carlo Broos | Interim CFO | Grant, award, or other acquisition of securities at price $ 5.75 per share. | 11 Nov 2024 | 20,500 | 78,844 (0%) | 0% | 5.8 | 117,875 | Common Stock |
| Rory B. Riggs | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 4.00 per share. | 18 Sep 2024 | 250,000 | 3,451,828 (10%) | 0% | 4 | 1,000,000 | Class A Common Stock |
| Greg Gocal | Chief Scientific Officer & EVP | Sale of securities on an exchange or to another person at price $ 10.01 per share. | 15 Jul 2024 | 2,000 | 314,844 (0%) | 0% | 10.0 | 20,023 | Class A Common Stock |
| Greg Gocal | Chief Scientific Officer & EVP | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 12 Jul 2024 | 2,000 | 316,844 (0%) | 0% | 10 | 20,000 | Class A Common Stock |
| Greg Gocal | Chief Scientific Officer & EVP | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 27 Jun 2024 | 2,000 | 318,844 (0%) | 0% | 10 | 20,000 | Class A Common Stock |
| Rory B. Riggs | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 98,040 | 98,040 | - | - | Common Warrant | |
| Rory B. Riggs | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 10.20 per share. | 11 Jun 2024 | 98,040 | 3,201,828 (9%) | 0% | 10.2 | 1,000,008 | Class A Common Stock |
| Jean-Pierre Jules Lehmann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 4,565 | 4,565 | - | - | Stock Option (Right-to-Buy) | |
| Jean-Pierre Jules Lehmann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 7,712 | 7,712 | - | - | Stock Option (Right-to-Buy) | |
| Jean-Pierre Jules Lehmann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 6,072 | 77,857 (0%) | 0% | 0 | Class A Common Stock | |
| Jean-Pierre Jules Lehmann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 4,565 | 4,565 | - | - | Stock Option (Right-to-Buy) | |
| Keith Allen Walker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 4,565 | 4,565 | - | - | Stock Option (Right-to-Buy) | |
| Keith Allen Walker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 7,712 | 7,712 | - | - | Stock Option (Right-to-Buy) | |
| Gerhard Prante | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 4,565 | 4,565 | - | - | Stock Option (Right-to-Buy) | |
| Gerhard Prante | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 6,072 | 77,857 (0%) | 0% | 0 | Class A Common Stock | |
| Mark Terrence Finn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 4,565 | 4,565 | - | - | Stock Option (Right-to-Buy) | |
| Mark Terrence Finn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 7,712 | 7,712 | - | - | Stock Option (Right-to-Buy) | |
| Riggs Rory B. | Director, Chief Executive Officer, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 29 Dec 2023 | 1,505,967 | 2,867,193 | - | - | Cibus Common Units | |
| Rory B. Riggs | Director, Chief Executive Officer, Ten Percent Owner | 29 Dec 2023 | 1,500,000 | 1,367,193 | - | - | Cibus Common Units | ||
| Riggs Rory B. | Director, Chief Executive Officer, Ten Percent Owner | 29 Dec 2023 | 1,500,000 | 3,103,788 (9%) | 4% | 0 | Class A Common Stock | ||
| B. Rory Riggs | Director, Chief Executive Officer, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 29 Dec 2023 | 1,505,967 | 2,867,193 | - | 0 | Class B Common Stock | |
| B. Rory Riggs | Director, Chief Executive Officer, Ten Percent Owner | 29 Dec 2023 | 1,500,000 | 1,367,193 | - | 0 | Class B Common Stock | ||
| Rory B. Riggs | Director, Chief Executive Officer, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 12 Dec 2023 | 50,000 | 50,000 | - | - | Pre-Funded Warrant | |
| B. Riggs Rory | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 10.58 per share. | 12 Dec 2023 | 517,107 | 1,622,495 (4%) | 1% | 10.6 | 5,470,992 | Class A Common Stock |
| B. Rory Riggs | Director, Chief Executive Officer, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 12 Dec 2023 | 39,476 | 1,105,388 (3%) | 0% | 0 | Class A Common Stock | |
| Wade Hampton King | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 8,556 | 8,556 | - | - | Class B Common Stock | |
| Wade Hampton King | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 88,482 | 88,482 (0%) | 0% | - | Class A Common Stock | |
| Wade Hampton King | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 8,556 | 8,556 | - | - | Cibus Common Units | |
| Wade Hampton King | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 123,618 | 212,100 (0%) | 0% | - | Class A Common Stock | |
| Jean-Pierre Jules Lehmann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 1,687,071 | 1,687,071 (5%) | 5% | - | Class A Common Stock | |
| Keith Allen Walker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 14,518 | 14,518 | - | - | Cibus Common Units | |
| Keith Allen Walker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 84,183 | 84,183 (0%) | 0% | - | Class A Common Stock | |
| Keith Allen Walker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 14,518 | 14,518 | - | - | Class B Common Stock | |
| Greg Gocal | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 242,322 | 242,322 (0%) | 0% | - | Class A Common Stock | |
| Greg Gocal | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 78,522 | 320,844 (0%) | 0% | - | Class A Common Stock | |
| Peter Beetham | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 87,649 | 378,934 (1%) | 0% | - | Class A Common Stock | |
| Peter Beetham | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 3,503 | 3,503 | - | - | Class B Common Stock | |
| Peter Beetham | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 3,503 | 3,503 | - | - | Cibus Common Units | |
| Peter Beetham | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 291,285 | 291,285 (0%) | 0% | - | Class A Common Stock | |
| Gerhard Prante | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 71,785 | 71,785 (0%) | 0% | - | Class A Common Stock | |
| Mark Terrence Finn | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 12,048 | 25,396 | - | - | Class B Common Stock | |
| Mark Terrence Finn | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 1,505,967 | 1,531,363 | - | - | Cibus Global Common Units | |
| Mark Terrence Finn | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 1,505,967 | 1,531,363 | - | - | Class B Common Stock | |
| Mark Terrence Finn | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 12,048 | 25,396 | - | - | Cibus Global Common Units | |
| Mark Terrence Finn | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 13,405 | 1,222,566 (3%) | 0% | - | Class A Common Stock | |
| Mark Terrence Finn | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 118,893 | 1,341,459 (4%) | 0% | - | Class A Common Stock | |
| William F. Koschak | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 30 Mar 2023 | 10,945 | 658,645 (1%) | 0% | 0 | Common Stock | |
| William F. Koschak | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.34 per share. | 27 Mar 2023 | 11,967 | 669,590 (2%) | 0% | 0.3 | 4,069 | Common Stock |
| Debra H. Frimerman | General Counsel and Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.34 per share. | 27 Mar 2023 | 11,967 | 661,902 (2%) | 0% | 0.3 | 4,069 | Common Stock |
| Travis F. Frey | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.34 per share. | 27 Mar 2023 | 11,967 | 666,327 (2%) | 0% | 0.3 | 4,069 | Common Stock |
| Michael A. Carr | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.34 per share. | 27 Mar 2023 | 16,025 | 882,011 (2%) | 0% | 0.3 | 5,449 | Common Stock |
| William F. Koschak | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.31 per share. | 14 Mar 2023 | 2,483 | 681,557 (2%) | 0% | 0.3 | 770 | Common Stock |
| Debra H. Frimerman | General Counsel and Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.31 per share. | 14 Mar 2023 | 2,621 | 673,869 (2%) | 0% | 0.3 | 813 | Common Stock |
| Travis F. Frey | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.31 per share. | 14 Mar 2023 | 2,276 | 678,294 (2%) | 0% | 0.3 | 706 | Common Stock |
| William F. Koschak | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.43 per share. | 07 Mar 2023 | 11,967 | 684,040 (2%) | 0% | 0.4 | 5,147 | Common Stock |
| Debra H. Frimerman | General Counsel and Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.43 per share. | 07 Mar 2023 | 11,967 | 676,490 (2%) | 0% | 0.4 | 5,147 | Common Stock |
| Travis F. Frey | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.43 per share. | 07 Mar 2023 | 11,967 | 680,570 (2%) | 0% | 0.4 | 5,147 | Common Stock |
| Michael A. Carr | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.43 per share. | 07 Mar 2023 | 20,261 | 898,036 (2%) | 0% | 0.4 | 8,714 | Common Stock |
| Kimberly K. Nelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 37,100 | 37,100 | - | - | Stock Option (Right-to-Buy) | |
| Kimberly K. Nelson | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Mar 2023 | 37,100 | 0 | - | - | Stock Option (Right-to-Buy) | |
| Kimberly K. Nelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 15,231 | 15,231 | - | - | Stock Option (Right-to-Buy) | |
| Kimberly K. Nelson | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Mar 2023 | 15,231 | 0 | - | - | Stock Option (Right-to-Buy) | |
| Kimberly K. Nelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 7,500 | 7,500 | - | - | Stock Option (Right-to-Buy) | |
| Kimberly K. Nelson | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Mar 2023 | 7,500 | 0 | - | - | Stock Option (Right-to-Buy) | |
| Yves J. Ribeill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 47,200 | 47,200 | - | - | Stock Option (Right-to-Buy) | |
| Yves J. Ribeill | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Mar 2023 | 47,200 | 0 | - | - | Stock Option (Right-to-Buy) | |
| Yves J. Ribeill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 10,291 | 10,291 | - | - | Stock Option (Right-to-Buy) | |
| Yves J. Ribeill | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Mar 2023 | 10,291 | 0 | - | - | Stock Option (Right-to-Buy) | |
| Yves J. Ribeill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 25,000 | 25,000 | - | - | Stock Option (Right-to-Buy) | |
| Yves J. Ribeill | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Mar 2023 | 25,000 | 0 | - | - | Stock Option (Right-to-Buy) | |
| Christopher J. Neugent | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 14,408 | 14,408 | - | - | Stock Option (Right-to-Buy) | |
| Christopher J. Neugent | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Mar 2023 | 7,500 | 0 | - | - | Stock Option (Right-to-Buy) | |
| Christopher J. Neugent | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 7,500 | 7,500 | - | - | Stock Option (Right-to-Buy) | |
| Christopher J. Neugent | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Mar 2023 | 14,408 | 0 | - | - | Stock Option (Right-to-Buy) | |
| Christopher J. Neugent | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Mar 2023 | 36,400 | 0 | - | - | Stock Option (Right-to-Buy) | |
| Christopher J. Neugent | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 36,400 | 36,400 | - | - | Stock Option (Right-to-Buy) | |
| Philippe Dumont | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 32,700 | 32,700 | - | - | Stock Option (Right-to-Buy) | |
| Philippe Dumont | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Mar 2023 | 32,700 | 0 | - | - | Stock Option (Right-to-Buy) | |
| Philippe Dumont | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 10,291 | 10,291 | - | - | Stock Option (Right-to-Buy) | |
| Philippe Dumont | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Mar 2023 | 10,291 | 0 | - | - | Stock Option (Right-to-Buy) | |
| Philippe Dumont | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 5,000 | 5,000 | - | - | Stock Option (Right-to-Buy) | |
| Philippe Dumont | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Mar 2023 | 5,000 | 0 | - | - | Stock Option (Right-to-Buy) | |
| Anna Ewa Kozicz-Stankiewicz | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Mar 2023 | 12,761 | 0 | - | - | Stock Option (Right-to-Buy) | |
| Anna Ewa Kozicz-Stankiewicz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 34,900 | 34,900 | - | - | Stock Option (Right-to-Buy) | |
| Anna Ewa Kozicz-Stankiewicz | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Mar 2023 | 34,900 | 0 | - | - | Stock Option (Right-to-Buy) | |
| Anna Ewa Kozicz-Stankiewicz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 12,761 | 12,761 | - | - | Stock Option (Right-to-Buy) | |
| Anna Ewa Kozicz-Stankiewicz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 5,000 | 5,000 | - | - | Stock Option (Right-to-Buy) | |
| Anna Ewa Kozicz-Stankiewicz | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Mar 2023 | 5,000 | 0 | - | - | Stock Option (Right-to-Buy) | |
| Jonathan B. Fassberg | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Mar 2023 | 32,700 | 0 | - | - | Stock Option (Right-to-Buy) | |
| Jonathan B. Fassberg | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Mar 2023 | 5,000 | 0 | - | - | Stock Option (Right-to-Buy) | |
| Jonathan B. Fassberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 5,000 | 5,000 | - | - | Stock Option (Right-to-Buy) | |
| Jonathan B. Fassberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 32,700 | 32,700 | - | - | Stock Option (Right-to-Buy) | |
| Jonathan B. Fassberg | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Mar 2023 | 10,291 | 0 | - | - | Stock Option (Right-to-Buy) | |
| Jonathan B. Fassberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 10,291 | 10,291 | - | - | Stock Option (Right-to-Buy) | |
| William F. Koschak | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 33,333 | 696,007 (2%) | 0% | 0 | Common Stock | |
| William F. Koschak | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 473,900 | 662,674 (2%) | 1% | 0 | Common Stock | |
| Debra H. Frimerman | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 33,333 | 688,457 (2%) | 0% | 0 | Common Stock | |
| Debra H. Frimerman | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 473,900 | 655,124 (1%) | 1% | 0 | Common Stock | |
| Travis F. Frey | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 473,900 | 659,204 (1%) | 1% | 0 | Common Stock | |
| Travis F. Frey | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 33,333 | 692,537 (2%) | 0% | 0 | Common Stock | |
| Michael A. Carr | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 68,333 | 918,297 (2%) | 0% | 0 | Common Stock | |
| Michael A. Carr | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 473,900 | 849,964 (2%) | 1% | 0 | Common Stock | |
| William F. Koschak | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 07 Feb 2023 | 23,751 | 188,774 (0%) | 0% | 0 | Common Stock | |
| William F. Koschak | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.15 per share. | 01 Jan 2023 | 42,570 | 212,525 (0%) | 0% | 0.1 | 6,279 | Common Stock |
| Debra H. Frimerman | General Counsel and Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.15 per share. | 01 Jan 2023 | 35,724 | 181,224 (0%) | 0% | 0.1 | 5,269 | Common Stock |
| Travis F. Frey | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.15 per share. | 01 Jan 2023 | 37,573 | 185,304 (0%) | 0% | 0.1 | 5,542 | Common Stock |
| Michael A. Carr | President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.15 per share. | 01 Jan 2023 | 47,877 | 376,064 (1%) | 0% | 0.1 | 7,062 | Common Stock |
| Yves J. Ribeill | Director | Sale of securities on an exchange or to another person at price $ 0.24 per share. | 19 Sep 2022 | 30,000 | 99,225 (0%) | 0% | 0.2 | 7,173 | Common Stock |
| Michael A. Carr | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.22 per share. | 27 Jul 2022 | 4,059 | 423,941 (1%) | 0% | 0.2 | 893 | Common Stock |
| Kimberly K. Nelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2022 | 37,100 | 37,100 | - | - | Stock Option (Right-to-Buy) | |
| Yves J. Ribeill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2022 | 47,200 | 47,200 | - | - | Stock Option (Right-to-Buy) | |
| Christopher J. Neugent | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2022 | 36,400 | 36,400 | - | - | Stock Option (Right-to-Buy) | |
| Philippe Dumont | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2022 | 32,700 | 32,700 | - | - | Stock Option (Right-to-Buy) | |
| Anna Ewa Kozicz-Stankiewicz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2022 | 34,900 | 34,900 | - | - | Stock Option (Right-to-Buy) | |
| Jonathan B. Fassberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2022 | 32,700 | 32,700 | - | - | Stock Option (Right-to-Buy) | |
| William Koschak | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2022 | 250,000 | 250,000 | - | - | Stock Option (Right-to-Buy) | |
| William Koschak | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2022 | 100,000 | 135,395 (0%) | 0% | 0 | Common Stock | |
| William Koschak | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2022 | 119,700 | 255,095 (0%) | 0% | 0 | Common Stock | |
| Debra H. Frimerman | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2022 | 250,000 | 250,000 | - | - | Stock Option (Right-to-Buy) | |
| Debra H. Frimerman | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2022 | 100,450 | 216,948 (0%) | 0% | 0 | Common Stock | |
| Debra H. Frimerman | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2022 | 100,000 | 116,498 (0%) | 0% | 0 | Common Stock | |
| Travis Frey | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2022 | 100,000 | 117,227 (0%) | 0% | 0 | Common Stock | |
| Travis Frey | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2022 | 250,000 | 250,000 | - | - | Stock Option (Right-to-Buy) | |
| Travis Frey | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2022 | 105,650 | 222,877 (0%) | 0% | 0 | Common Stock | |
| Michael A. Carr | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2022 | 205,000 | 265,000 (0%) | 0% | 0 | Common Stock | |
| Michael A. Carr | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2022 | 490,000 | 490,000 | - | - | Stock Option (Right-to-Buy) | |
| Michael A. Carr | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2022 | 163,000 | 428,000 (1%) | 0% | 0 | Common Stock | |
| Yves J. Ribeill | Director | Sale of securities on an exchange or to another person at price $ 1.06 per share. | 21 Mar 2022 | 20,000 | 129,225 (0%) | 0% | 1.1 | 21,238 | Common Stock |
| William Koschak | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.05 per share. | 14 Mar 2022 | 2,605 | 35,395 (0%) | 0% | 1.1 | 2,740 | Common Stock |
| Debra H. Frimerman | General Counsel and Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.08 per share. | 14 Mar 2022 | 2,502 | 16,498 (0%) | 0% | 1.1 | 2,702 | Common Stock |
| Travis Frey | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.08 per share. | 14 Mar 2022 | 2,173 | 17,227 (0%) | 0% | 1.1 | 2,347 | Common Stock |
| Michael A. Carr | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 3.98 per share. | 30 Aug 2021 | 10,000 | 60,000 (0%) | 0% | 4.0 | 39,776 | Common Stock |
| William Koschak | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 3.21 per share. | 19 Aug 2021 | 20,000 | 38,000 (0%) | 0% | 3.2 | 64,112 | Common Stock |
| Yves J. Ribeill | Director, Executive Chair | Grant, award, or other acquisition of securities at price $ 3.65 per share. | 27 Jul 2021 | 50,429 | 149,225 (0%) | 0% | 3.7 | 184,066 | Common Stock |
| Michael A. Carr | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jul 2021 | 600,000 | 600,000 | - | - | Performance Stock Units | |
| Michael A. Carr | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jul 2021 | 200,000 | 200,000 | - | - | Stock Option (Right-to-Buy) | |
| Michael A. Carr | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 3.65 per share. | 27 Jul 2021 | 50,000 | 50,000 (0%) | 0% | 3.7 | 182,500 | Common Stock |
| Yves J. Ribeill | Director, Executive Chair | Grant, award, or other acquisition of securities at price $ 4.07 per share. | 01 Jul 2021 | 12,048 | 98,796 (0%) | 0% | 4.1 | 49,035 | Common Stock |
| Yves J. Ribeill | Director, Executive Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 11,967 | 86,748 (0%) | 0% | 0 | Common Stock | |
| Kimberly K. Nelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2021 | 15,231 | 15,231 | - | - | Stock Option (Right-to-Buy) | |
| Kimberly K. Nelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2021 | 7,204 | 7,204 (0%) | 0% | 0 | Common Stock | |
| Yves J. Ribeill | Director, Executive Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2021 | 10,291 | 10,291 | - | - | Stock Option (Right-to-Buy) | |
| Yves J. Ribeill | Director, Executive Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2021 | 18,730 | 74,781 (0%) | 0% | 0 | Common Stock | |
| Christopher J. Neugent | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2021 | 7,204 | 31,804 (0%) | 0% | 0 | Common Stock | |
| Christopher J. Neugent | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2021 | 14,408 | 14,408 | - | - | Stock Option (Right-to-Buy) | |
| Philippe Dumont | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2021 | 7,204 | 27,614 (0%) | 0% | 0 | Common Stock | |
| Philippe Dumont | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2021 | 10,291 | 10,291 | - | - | Stock Option (Right-to-Buy) | |
| Anna Ewa Kozicz-Stankiewicz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2021 | 7,204 | 24,089 (0%) | 0% | 0 | Common Stock | |
| Anna Ewa Kozicz-Stankiewicz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2021 | 12,761 | 12,761 | - | - | Stock Option (Right-to-Buy) | |
| Jonathan B. Fassberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2021 | 10,291 | 10,291 | - | - | Stock Option (Right-to-Buy) | |
| Jonathan B. Fassberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2021 | 7,204 | 26,804 (0%) | 0% | 0 | Common Stock | |
| Christopher J. Neugent | Director | Purchase of securities on an exchange or from another person at price $ 3.95 per share. | 12 May 2021 | 15,000 | 15,000 (0%) | 0% | 4.0 | 59,291 | Common Stock |
| Yves J. Ribeill | Director, Executive Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2021 | 9,430 | 56,051 (0%) | 0% | 0 | Common Stock | |
| Yves J. Ribeill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 16,591 | 46,621 (0%) | 0% | 0 | Common Stock | |
| Christopher J. Neugent | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2021 | 5,000 | 7,940 (0%) | 0% | 0 | Common Stock | |
| William Koschak | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2021 | 26,000 | 26,000 | - | - | Stock Option (Right-to-Buy) | |
| William Koschak | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2021 | 18,000 | 18,000 (0%) | 0% | 0 | Common Stock | |
| Debra H. Frimerman | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2021 | 19,000 | 19,000 (0%) | 0% | 0 | Common Stock | |
| Debra H. Frimerman | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2021 | 27,000 | 27,000 | - | - | Stock Option (Right-to-Buy) | |
| Travis Frey | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2021 | 16,500 | 19,400 (0%) | 0% | 0 | Common Stock | |
| Travis Frey | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2021 | 24,000 | 24,000 | - | - | Stock Option (Right-to-Buy) | |
| Daniel Voytas | Chief Science Officer | Sale of securities on an exchange or to another person at price $ 4.13 per share. | 04 Jan 2021 | 2,513 | 0 (0%) | 0% | 4.1 | 10,388 | Common Stock |
| Daniel Voytas | Chief Science Officer | Sale of securities on an exchange or to another person at price $ 4.75 per share. | 18 Dec 2020 | 5,026 | 2,513 (0%) | 0% | 4.8 | 23,874 | Common Stock |
| Travis Frey | Chief Technology Officer | Purchase of securities on an exchange or from another person at price $ 3.79 per share. | 01 Dec 2020 | 150 | 2,900 (0%) | 0% | 3.8 | 569 | Common Stock |
| Travis Frey | Chief Technology Officer | Purchase of securities on an exchange or from another person at price $ 3.26 per share. | 02 Nov 2020 | 150 | 2,750 (0%) | 0% | 3.3 | 489 | Common Stock |
| Travis Frey | Chief Technology Officer | Purchase of securities on an exchange or from another person at price $ 5.47 per share. | 01 Oct 2020 | 150 | 2,600 (0%) | 0% | 5.5 | 820 | Common Stock |
| James A. Blome | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 5.59 per share. | 30 Sep 2020 | 4,140 | 190,422 (0%) | 0% | 5.6 | 23,124 | Common Stock |
| Philippe Dumont | Director | Purchase of securities on an exchange or from another person at price $ 5.91 per share. | 10 Sep 2020 | 3,000 | 6,290 (0%) | 0% | 5.9 | 17,729 | Common Stock |
| Travis Frey | Chief Technology Officer | Purchase of securities on an exchange or from another person at price $ 5.41 per share. | 01 Sep 2020 | 150 | 2,450 (0%) | 0% | 5.4 | 811 | Common Stock |
| Kimberly K. Nelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2020 | 7,500 | 7,500 | - | - | Stock Option (Right-to-Buy) | |
| Yves J. Ribeill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2020 | 25,000 | 25,000 | - | - | Stock Option (Right-to-Buy) | |
| Christopher J. Neugent | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2020 | 7,500 | 7,500 | - | - | Stock Option (Right-to-Buy) | |
| Daniel Voytas | Chief Science Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2020 | 65,000 | 65,000 | - | - | Stock Option (Right-to-Buy) | |
| Philippe Dumont | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2020 | 5,000 | 5,000 | - | - | Stock Option (Right-to-Buy) | |
| Anna Ewa Kozicz-Stankiewicz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2020 | 5,000 | 5,000 | - | - | Stock Option (Right-to-Buy) | |
| Jonathan B. Fassberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2020 | 5,000 | 5,000 | - | - | Stock Option (Right-to-Buy) | |
| James A. Blome | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2020 | 175,000 | 175,000 | - | - | Stock Option (Right-to-Buy) | |
| William Koschak | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2020 | 110,000 | 110,000 | - | - | Stock Option (Right-to-Buy) | |
| Debra H. Frimerman | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2020 | 80,000 | 80,000 | - | - | Stock Option (Right-to-Buy) | |
| Travis Frey | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2020 | 80,000 | 80,000 | - | - | Stock Option (Right-to-Buy) | |
| Travis Frey | Chief Technology Officer | Purchase of securities on an exchange or from another person at price $ 4.36 per share. | 03 Aug 2020 | 150 | 2,300 (0%) | 0% | 4.4 | 654 | Common Stock |
| Andre Choulika | Director | Sale of securities on an exchange or to another person at price $ 4.65 per share. | 01 Jul 2020 | 4,228 | 130,815 (0%) | 0% | 4.6 | 19,647 | Common Stock |
| Travis Frey | Chief Technology Officer | Purchase of securities on an exchange or from another person at price $ 5.04 per share. | 01 Jul 2020 | 156 | 2,150 (0%) | 0% | 5.0 | 786 | Common Stock |
| James A. Blome | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 5.01 per share. | 29 Jun 2020 | 2,902 | 198,057 (0%) | 0% | 5.0 | 14,532 | Common Stock |
| James A. Blome | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 4.65 per share. | 29 Jun 2020 | 3,495 | 194,562 (0%) | 0% | 4.7 | 16,268 | Common Stock |
| Travis Frey | Chief Technology Officer | Purchase of securities on an exchange or from another person at price $ 4.43 per share. | 01 Jun 2020 | 144 | 1,994 (0%) | 0% | 4.4 | 638 | Common Stock |
| Travis Frey | Chief Technology Officer | Purchase of securities on an exchange or from another person at price $ 4.31 per share. | 01 May 2020 | 175 | 1,850 (0%) | 0% | 4.3 | 755 | Common Stock |
| Philippe Dumont | Director | Sale of securities on an exchange or to another person at price $ 2.87 per share. | 02 Apr 2020 | 236 | 1,526 (0%) | 0% | 2.9 | 677 | Common Stock |
| Philippe Dumont | Director | Sale of securities on an exchange or to another person at price $ 4.70 per share. | 02 Apr 2020 | 236 | 1,290 (0%) | 0% | 4.7 | 1,109 | Common Stock |
| Philippe Dumont | Director | Purchase of securities on an exchange or from another person at price $ 7.48 per share. | 02 Apr 2020 | 2,000 | 3,290 (0%) | 0% | 7.5 | 14,970 | Common Stock |
| Anna Ewa Kozicz-Stankiewicz | Director | Sale of securities on an exchange or to another person at price $ 4.70 per share. | 02 Apr 2020 | 245 | 3,165 (0%) | 0% | 4.7 | 1,152 | Common Stock |
| Anna Ewa Kozicz-Stankiewicz | Director | Sale of securities on an exchange or to another person at price $ 2.87 per share. | 02 Apr 2020 | 245 | 3,410 (0%) | 0% | 2.9 | 703 | Common Stock |
| Travis Frey | Chief Technology Officer | Purchase of securities on an exchange or from another person at price $ 3.19 per share. | 01 Apr 2020 | 175 | 1,675 (0%) | 0% | 3.2 | 559 | Common Stock |
| Andre Choulika | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.95 per share. | 31 Mar 2020 | 3,690 | 135,043 (0%) | 0% | 3.0 | 10,903 | Common Stock |
| James A. Blome | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.96 per share. | 31 Mar 2020 | 3,177 | 200,959 (0%) | 0% | 3.0 | 9,389 | Common Stock |
| Travis Frey | Chief Technology Officer | Purchase of securities on an exchange or from another person at price $ 6.43 per share. | 02 Mar 2020 | 200 | 1,500 (0%) | 0% | 6.4 | 1,286 | Common Stock |
| Yves J. Ribeill | Director | Sale of securities on an exchange or to another person at price $ 5.46 per share. | 28 Feb 2020 | 300 | 34,834 (0%) | 0% | 5.5 | 1,637 | Common Stock |
| Yves J. Ribeill | Director | Sale of securities on an exchange or to another person at price $ 5.45 per share. | 28 Feb 2020 | 802 | 35,134 (0%) | 0% | 5.5 | 4,371 | Common Stock |
| Yves J. Ribeill | Director | Sale of securities on an exchange or to another person at price $ 5.44 per share. | 28 Feb 2020 | 890 | 35,936 (0%) | 0% | 5.4 | 4,842 | Common Stock |
| Yves J. Ribeill | Director | Sale of securities on an exchange or to another person at price $ 5.48 per share. | 28 Feb 2020 | 602 | 32,432 (0%) | 0% | 5.5 | 3,299 | Common Stock |
| Yves J. Ribeill | Director | Sale of securities on an exchange or to another person at price $ 5.42 per share. | 28 Feb 2020 | 200 | 38,120 (0%) | 0% | 5.4 | 1,084 | Common Stock |
| Yves J. Ribeill | Director | Sale of securities on an exchange or to another person at price $ 5.47 per share. | 28 Feb 2020 | 700 | 33,034 (0%) | 0% | 5.5 | 3,829 | Common Stock |
| Yves J. Ribeill | Director | Sale of securities on an exchange or to another person at price $ 5.46 per share. | 28 Feb 2020 | 1,100 | 33,734 (0%) | 0% | 5.5 | 6,006 | Common Stock |
| Yves J. Ribeill | Director | Sale of securities on an exchange or to another person at price $ 5.50 per share. | 28 Feb 2020 | 1,700 | 30,732 (0%) | 0% | 5.5 | 9,350 | Common Stock |
| Yves J. Ribeill | Director | Sale of securities on an exchange or to another person at price $ 5.51 per share. | 28 Feb 2020 | 302 | 30,430 (0%) | 0% | 5.5 | 1,664 | Common Stock |
| Yves J. Ribeill | Director | Sale of securities on an exchange or to another person at price $ 5.54 per share. | 28 Feb 2020 | 400 | 30,030 (0%) | 0% | 5.5 | 2,216 | Common Stock |
| Yves J. Ribeill | Director | Sale of securities on an exchange or to another person at price $ 5.41 per share. | 28 Feb 2020 | 1,700 | 38,320 (0%) | 0% | 5.4 | 9,197 | Common Stock |
| Yves J. Ribeill | Director | Sale of securities on an exchange or to another person at price $ 5.44 per share. | 28 Feb 2020 | 200 | 36,826 (0%) | 0% | 5.4 | 1,087 | Common Stock |
| Yves J. Ribeill | Director | Sale of securities on an exchange or to another person at price $ 5.43 per share. | 28 Feb 2020 | 894 | 37,026 (0%) | 0% | 5.4 | 4,854 | Common Stock |
| Yves J. Ribeill | Director | Sale of securities on an exchange or to another person at price $ 5.42 per share. | 28 Feb 2020 | 200 | 37,920 (0%) | 0% | 5.4 | 1,085 | Common Stock |
| Travis Frey | Chief Technology Officer | Purchase of securities on an exchange or from another person at price $ 5.61 per share. | 03 Feb 2020 | 200 | 1,300 (0%) | 0% | 5.6 | 1,122 | Common Stock |
| Travis Frey | Chief Technology Officer | Purchase of securities on an exchange or from another person at price $ 7.89 per share. | 15 Jan 2020 | 275 | 1,100 (0%) | 0% | 7.9 | 2,170 | Common Stock |
| Travis Frey | Chief Technology Officer | Purchase of securities on an exchange or from another person at price $ 7.24 per share. | 13 Jan 2020 | 275 | 825 (0%) | 0% | 7.2 | 1,990 | Common Stock |
| Travis Frey | Chief Technology Officer | Purchase of securities on an exchange or from another person at price $ 7.19 per share. | 13 Jan 2020 | 275 | 550 (0%) | 0% | 7.2 | 1,977 | Common Stock |
| Travis Frey | Chief Technology Officer | Purchase of securities on an exchange or from another person at price $ 7.64 per share. | 10 Jan 2020 | 275 | 275 (0%) | 0% | 7.6 | 2,101 | Common Stock |
| Philippe Dumont | Director | Sale of securities on an exchange or to another person at price $ 7.60 per share. | 03 Jan 2020 | 236 | 1,762 (0%) | 0% | 7.6 | 1,794 | Common Stock |
| Anna Ewa Kozicz-Stankiewicz | Director | Sale of securities on an exchange or to another person at price $ 7.65 per share. | 03 Jan 2020 | 245 | 3,655 (0%) | 0% | 7.6 | 1,874 | Common Stock |
| Philippe Dumont | Director | Sale of securities on an exchange or to another person at price $ 4.96 per share. | 02 Oct 2019 | 236 | 1,998 (0%) | 0% | 5.0 | 1,171 | Common Stock |
| Anna Ewa Kozicz-Stankiewicz | Director | Sale of securities on an exchange or to another person at price $ 4.96 per share. | 02 Oct 2019 | 245 | 3,900 (0%) | 0% | 5.0 | 1,215 | Common Stock |
| Philippe Dumont | Director | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 18 Jul 2019 | 706 | 16,354 (0%) | 0% | 10 | 7,060 | Common Stock |
| Anna Ewa Kozicz-Stankiewicz | Director | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 18 Jul 2019 | 735 | 17,865 (0%) | 0% | 10 | 7,350 | Common Stock |
| Manoj Sahoo | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 12.70 per share. | 01 Jul 2019 | 1,494 | 65,323 (0%) | 0% | 12.7 | 18,967 | Common Stock |
| Daniel Voytas | Chief Science Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2019 | 50,000 | 142,982 (0%) | 0% | 0 | Common Stock | |
| James A. Blome | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2019 | 125,000 | 125,000 | - | - | Stock Option (Right-to-Buy) | |
| James A. Blome | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2019 | 166,667 | 166,667 | - | - | Performance Stock Units | |
| James A. Blome | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2019 | 50,000 | 204,136 (0%) | 0% | 0 | Common Stock | |
| William Koschak | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2019 | 85,000 | 85,000 | - | - | Performance Stock Units | |
| Debra H. Frimerman | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2019 | 60,000 | 60,000 | - | - | Performance Stock Units | |
| Andre Choulika | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.90 per share. | 14 Jun 2019 | 15,715 | 138,733 (0%) | 0% | 12.9 | 202,724 | Common Stock |
| Travis Frey | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2019 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Andre Choulika | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2019 | 17,500 | 17,500 | - | - | Stock Option (Right to Buy) | |
| Debra H. Frimerman | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2019 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Kimberly K. Nelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2019 | 55,000 | 55,000 | - | - | Stock Option (Right to Buy) | |
| Yves J. Ribeill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2019 | 7,500 | 7,500 | - | - | Stock Option (Right to Buy) | |
| Andre Choulika | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2019 | 7,500 | 7,500 | - | - | Stock Option (Right to Buy) | |
| Christopher J. Neugent | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2019 | 5,000 | 5,000 | - | - | Stock Option (Right to Buy) | |
| Philippe Dumont | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2019 | 7,500 | 7,500 | - | - | Stock Option (Right to Buy) | |
| Anna Ewa Kozicz-Stankiewicz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2019 | 5,000 | 5,000 | - | - | Stock Option (Right to Buy) | |
| Jonathan B. Fassberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2019 | 5,000 | 5,000 | - | - | Stock Option (Right to Buy) | |
| Daniel Voytas | Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2019 | 3,750 | 204,611 | - | - | Stock Option (Right to Buy) | |
| Daniel Voytas | Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.59 per share. | 29 Apr 2019 | 3,750 | 96,732 (0%) | 0% | 3.6 | 13,463 | Common Stock |
| Daniel Voytas | Chief Science Officer | Sale of securities on an exchange or to another person at price $ 16.31 per share. | 29 Apr 2019 | 3,750 | 92,982 (0%) | 0% | 16.3 | 61,152 | Common Stock |
| James A. Blome | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 16.65 per share. | 02 Apr 2019 | 2,582 | 154,136 (0%) | 0% | 16.6 | 42,982 | Common Stock |
| Manoj Sahoo | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 17.33 per share. | 01 Apr 2019 | 1,522 | 66,817 (0%) | 0% | 17.3 | 26,378 | Common Stock |
| James A. Blome | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 17.87 per share. | 26 Mar 2019 | 2,582 | 156,718 (0%) | 0% | 17.9 | 46,129 | Restricted Stock Units |
| James A. Blome | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 17.32 per share. | 19 Mar 2019 | 2,582 | 159,300 (0%) | 0% | 17.3 | 44,713 | Restricted Stock Units |
| James A. Blome | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 16.58 per share. | 12 Mar 2019 | 2,582 | 161,882 (0%) | 0% | 16.6 | 42,802 | Restricted Stock Units |
| Yves J. Ribeill | Director | Sale of securities on an exchange or to another person at price $ 16.76 per share. | 11 Mar 2019 | 5,000 | 50,000 (0%) | 0% | 16.8 | 83,819 | Restricted Stock Units |
| Yves J. Ribeill | Director | Sale of securities on an exchange or to another person at price $ 16.33 per share. | 11 Mar 2019 | 4,980 | 40,020 (0%) | 0% | 16.3 | 81,317 | Restricted Stock Units |
| Yves J. Ribeill | Director | Sale of securities on an exchange or to another person at price $ 16.08 per share. | 11 Mar 2019 | 5,000 | 45,000 (0%) | 0% | 16.1 | 80,410 | Restricted Stock Units |
| Yves J. Ribeill | Director | Sale of securities on an exchange or to another person at price $ 17.39 per share. | 11 Mar 2019 | 5,000 | 55,000 (0%) | 0% | 17.4 | 86,958 | Restricted Stock Units |
| Daniel Voytas | Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.59 per share. | 25 Feb 2019 | 3,977 | 96,959 (0%) | 0% | 3.6 | 14,277 | Common Stock |
| Daniel Voytas | Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2019 | 3,977 | 208,361 | - | - | Stock Option (Right to Buy) | |
| Daniel Voytas | Chief Science Officer | Sale of securities on an exchange or to another person at price $ 16.00 per share. | 25 Feb 2019 | 3,977 | 92,982 (0%) | 0% | 16 | 63,632 | Common Stock |
| William Koschak | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2019 | 180,000 | 180,000 | - | - | Stock Option (Right to Buy) | |
| Daniel Voytas | Chief Science Officer | Sale of securities on an exchange or to another person at price $ 13.00 per share. | 31 Jan 2019 | 4,083 | 92,982 (0%) | 0% | 13 | 53,079 | Common Stock |
| Daniel Voytas | Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2019 | 4,087 | 4,083 | - | - | Stock Option (Right to Buy) | |
| Daniel Voytas | Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2019 | 4,083 | 8,170 | - | - | Stock Option (Right to Buy) | |
| Daniel Voytas | Chief Science Officer | Sale of securities on an exchange or to another person at price $ 13.00 per share. | 31 Jan 2019 | 4,087 | 92,982 (0%) | 0% | 13 | 53,131 | Common Stock |
| Daniel Voytas | Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.71 per share. | 31 Jan 2019 | 4,087 | 97,069 (0%) | 0% | 3.7 | 15,180 | Common Stock |
| Daniel Voytas | Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.71 per share. | 31 Jan 2019 | 4,083 | 97,065 (0%) | 0% | 3.7 | 15,165 | Common Stock |
| Philippe Dumont | Director | Sale of securities on an exchange or to another person at price $ 12.00 per share. | 04 Jan 2019 | 1,117 | 17,060 (0%) | 0% | 12 | 13,404 | Common Stock |
| Manoj Sahoo | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 10.39 per share. | 02 Jan 2019 | 2,444 | 76,669 (0%) | 0% | 10.4 | 25,389 | Common Stock |
| James Blome | Chief Executive Officer | 31 Dec 2018 | 15,536 | 164,464 (0%) | 0% | 14.8 | 230,399 | Restricted Stock Units | |
| Daniel Voytas | Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.71 per share. | 18 Dec 2018 | 4,083 | 97,065 (0%) | 0% | 3.7 | 15,165 | Common Stock |
| Daniel Voytas | Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Dec 2018 | 4,083 | 12,253 | - | - | Stock Option (Right to Buy) | |
| Daniel Voytas | Chief Science Officer | Sale of securities on an exchange or to another person at price $ 13.00 per share. | 18 Dec 2018 | 4,083 | 92,982 (0%) | 0% | 13 | 53,079 | Common Stock |
| Daniel Voytas | Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Nov 2018 | 4,083 | 16,336 | - | - | Stock Option (Right to Buy) | |
| Daniel Voytas | Chief Science Officer | Sale of securities on an exchange or to another person at price $ 13.00 per share. | 08 Nov 2018 | 4,083 | 92,982 (0%) | 0% | 13 | 53,079 | Common Stock |
| Daniel Voytas | Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.71 per share. | 08 Nov 2018 | 4,083 | 97,065 (0%) | 0% | 3.7 | 15,165 | Common Stock |
| Daniel Voytas | Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.71 per share. | 09 Oct 2018 | 4,083 | 97,065 (0%) | 0% | 3.7 | 15,165 | Common Stock |
| Daniel Voytas | Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Oct 2018 | 4,083 | 20,419 | - | - | Stock Option (Right to Buy) | |
| Daniel Voytas | Chief Science Officer | Sale of securities on an exchange or to another person at price $ 13.84 per share. | 09 Oct 2018 | 4,083 | 92,982 (0%) | 0% | 13.8 | 56,514 | Common Stock |
| Christopher J. Neugent | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Oct 2018 | 29,400 | 29,400 | - | - | Stock Option (Right to Buy) | |
| Christopher J. Neugent | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Oct 2018 | 19,600 | 19,600 (0%) | 0% | 0 | Restricted Stock Units | |
| Jonathan B. Fassberg | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Oct 2018 | 19,600 | 19,600 (0%) | 0% | 0 | Restricted Stock Units | |
| Jonathan B. Fassberg | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Oct 2018 | 29,400 | 29,400 | - | - | Stock Option (Right to Buy) | |
| James Blome | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Oct 2018 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| Philippe Dumont | None | Sale of securities on an exchange or to another person at price $ 14.11 per share. | 05 Oct 2018 | 1,117 | 18,177 (0%) | 0% | 14.1 | 15,765 | Common Stock |
| Manoj Sahoo | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 14.84 per share. | 01 Oct 2018 | 2,521 | 79,113 (0%) | 0% | 14.8 | 37,416 | Common Stock |
| Daniel Voytas | Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.59 per share. | 20 Sep 2018 | 4,666 | 97,648 (0%) | 0% | 3.6 | 16,751 | Common Stock |
| Daniel Voytas | Chief Science Officer | Sale of securities on an exchange or to another person at price $ 16.00 per share. | 20 Sep 2018 | 4,666 | 92,982 (0%) | 0% | 16 | 74,656 | Common Stock |
| Daniel Voytas | Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Sep 2018 | 4,666 | 212,338 | - | - | Stock Option (Right to Buy) | |
| Daniel Voytas | Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.71 per share. | 10 Sep 2018 | 4,083 | 97,065 (0%) | 0% | 3.7 | 15,165 | Common Stock |
| Daniel Voytas | Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2018 | 4,083 | 24,502 | - | - | Stock Option (Right to Buy) | |
| Daniel Voytas | Chief Science Officer | Sale of securities on an exchange or to another person at price $ 16.13 per share. | 10 Sep 2018 | 4,083 | 92,982 (0%) | 0% | 16.1 | 65,842 | Common Stock |
| Yves J. Ribeill | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Aug 2018 | 180,000 | 180,000 | - | - | Stock Option (Right to Buy) | |
| Yves J. Ribeill | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Aug 2018 | 60,000 | 60,000 (0%) | 0% | 0 | Restricted Stock Units | |
| Daniel Voytas | Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Aug 2018 | 4,666 | 217,004 | - | - | Stock Option (Right to Buy) | |
| Daniel Voytas | Chief Science Officer | Sale of securities on an exchange or to another person at price $ 17.31 per share. | 20 Aug 2018 | 4,666 | 92,982 (0%) | 0% | 17.3 | 80,768 | Common Stock |
| Daniel Voytas | Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.59 per share. | 20 Aug 2018 | 4,666 | 97,648 (0%) | 0% | 3.6 | 16,751 | Common Stock |
| Daniel Voytas | Chief Science Officer | Sale of securities on an exchange or to another person at price $ 17.48 per share. | 08 Aug 2018 | 4,083 | 92,982 (0%) | 0% | 17.5 | 71,372 | Common Stock |
| Daniel Voytas | Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2018 | 4,083 | 28,585 | - | - | Stock Option (Right to Buy) | |
| Daniel Voytas | Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.71 per share. | 08 Aug 2018 | 4,083 | 97,065 (0%) | 0% | 3.7 | 15,165 | Common Stock |
| Daniel Voytas | Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jul 2018 | 4,666 | 221,670 | - | - | Stock Option (Right to Buy) | |
| Daniel Voytas | Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.59 per share. | 20 Jul 2018 | 4,666 | 97,648 (0%) | 0% | 3.6 | 16,751 | Common Stock |
| Daniel Voytas | Chief Science Officer | Sale of securities on an exchange or to another person at price $ 17.94 per share. | 20 Jul 2018 | 4,666 | 92,982 (0%) | 0% | 17.9 | 83,708 | Common Stock |
| Daniel Voytas | Chief Science Officer | Sale of securities on an exchange or to another person at price $ 17.84 per share. | 09 Jul 2018 | 4,083 | 92,982 (0%) | 0% | 17.8 | 72,822 | Common Stock |
| Daniel Voytas | Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2018 | 4,083 | 32,668 | - | - | Stock Option (Right to Buy) | |
| Daniel Voytas | Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.71 per share. | 09 Jul 2018 | 4,083 | 97,065 (0%) | 0% | 3.7 | 15,165 | Common Stock |
| Alain Godard | None | Sale of securities on an exchange or to another person at price $ 20.84 per share. | 21 Jun 2018 | 5,880 | 33,320 (0%) | 0% | 20.8 | 122,540 | Common Stock |
| Daniel Voytas | Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jun 2018 | 4,666 | 226,336 | - | - | Stock Option (Right to Buy) | |
| Daniel Voytas | Chief Science Officer | Sale of securities on an exchange or to another person at price $ 20.56 per share. | 20 Jun 2018 | 4,666 | 92,982 (0%) | 0% | 20.6 | 95,910 | Common Stock |
| Daniel Voytas | Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.59 per share. | 20 Jun 2018 | 4,666 | 97,648 (0%) | 0% | 3.6 | 16,751 | Common Stock |
| Michel Arbadji | Director of Business Developme | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.59 per share. | 20 Jun 2018 | 6,500 | 31,490 (0%) | 0% | 3.6 | 23,321 | Common Stock |
| Michel Arbadji | Director of Business Developme | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jun 2018 | 6,500 | 112,500 | - | - | Stock Option (Right to Buy) | |
| Michel Arbadji | Director of Business Developme | Sale of securities on an exchange or to another person at price $ 22.00 per share. | 20 Jun 2018 | 6,500 | 24,990 (0%) | 0% | 22 | 143,000 | Common Stock |
| Manoj Sahoo | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 20.51 per share. | 18 Jun 2018 | 490 | 81,634 (0%) | 0% | 20.5 | 10,050 | Common Stock |
| Andre Choulika | None | Sale of securities on an exchange or to another person at price $ 19.49 per share. | 15 Jun 2018 | 2,352 | 154,448 (0%) | 0% | 19.5 | 45,840 | Common Stock |
| Federico Tripodi | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 19.49 per share. | 15 Jun 2018 | 14,700 | 181,300 (0%) | 0% | 19.5 | 286,503 | Common Stock |
| Bryan W. J. Corkal | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 18.77 per share. | 15 Jun 2018 | 5,093 | 73,307 (0%) | 0% | 18.8 | 95,613 | Common Stock |
| Daniel Voytas | Chief Science Officer | Sale of securities on an exchange or to another person at price $ 19.49 per share. | 15 Jun 2018 | 7,539 | 92,982 (0%) | 0% | 19.5 | 146,935 | Common Stock |
| Manoj Sahoo | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 19.49 per share. | 15 Jun 2018 | 5,096 | 82,124 (0%) | 0% | 19.5 | 99,321 | Common Stock |
| Glenn Bowers | Vice President of Breeding | Sale of securities on an exchange or to another person at price $ 19.49 per share. | 15 Jun 2018 | 423 | 8,617 (0%) | 0% | 19.5 | 8,244 | Common Stock |
| Michel Arbadji | Director of Business Developme | Sale of securities on an exchange or to another person at price $ 18.75 per share. | 15 Jun 2018 | 4,410 | 24,990 (0%) | 0% | 18.8 | 82,706 | Common Stock |
| Philippe Dumont | None | Sale of securities on an exchange or to another person at price $ 19.49 per share. | 15 Jun 2018 | 706 | 19,294 (0%) | 0% | 19.5 | 13,760 | Common Stock |
| Anna Ewa Kozicz-Stankiewicz | None | Sale of securities on an exchange or to another person at price $ 19.49 per share. | 15 Jun 2018 | 1,000 | 18,600 (0%) | 0% | 19.5 | 19,490 | Common Stock |
| Daniel Voytas | Chief Science Officer | Sale of securities on an exchange or to another person at price $ 16.63 per share. | 21 May 2018 | 4,666 | 100,521 (0%) | 0% | 16.6 | 77,589 | Common Stock |
| Daniel Voytas | Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2018 | 4,666 | 231,002 | - | - | Stock Option (Right to Buy) | |
| Daniel Voytas | Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.59 per share. | 21 May 2018 | 4,666 | 105,187 (0%) | 0% | 3.6 | 16,751 | Common Stock |
| Daniel Voytas | Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.71 per share. | 08 May 2018 | 4,083 | 104,604 (0%) | 0% | 3.7 | 15,165 | Common Stock |
| Daniel Voytas | Chief Science Officer | Sale of securities on an exchange or to another person at price $ 15.58 per share. | 08 May 2018 | 4,083 | 100,521 (0%) | 0% | 15.6 | 63,596 | Common Stock |
| Daniel Voytas | Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2018 | 4,083 | 36,751 | - | - | Stock Option (Right to Buy) | |
| Daniel Voytas | Chief Science Officer | Sale of securities on an exchange or to another person at price $ 16.87 per share. | 20 Apr 2018 | 4,666 | 100,521 (0%) | 0% | 16.9 | 78,701 | Common Stock |
| Daniel Voytas | Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.59 per share. | 20 Apr 2018 | 4,666 | 105,187 (0%) | 0% | 3.6 | 16,751 | Common Stock |
| Daniel Voytas | Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Apr 2018 | 4,666 | 235,668 | - | - | Stock Option (Right to Buy) | |
| Daniel Voytas | Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.71 per share. | 09 Apr 2018 | 4,083 | 104,604 (0%) | 0% | 3.7 | 15,165 | Common Stock |
| Daniel Voytas | Chief Science Officer | Sale of securities on an exchange or to another person at price $ 14.39 per share. | 09 Apr 2018 | 4,083 | 100,521 (0%) | 0% | 14.4 | 58,734 | Common Stock |
| Daniel Voytas | Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2018 | 4,083 | 40,834 | - | - | Stock Option (Right to Buy) | |
| Daniel Voytas | Chief Science Officer | Sale of securities on an exchange or to another person at price $ 17.91 per share. | 20 Mar 2018 | 4,666 | 0 (0%) | 0% | 17.9 | 83,561 | Common Stock |
| Daniel Voytas | Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.59 per share. | 20 Mar 2018 | 4,666 | 4,666 (0%) | 0% | 3.6 | 16,741 | Common Stock |
| Daniel Voytas | Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Mar 2018 | 4,666 | 240,334 | - | - | Stock Option (Right to Buy) | |
| Daniel Voytas | Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2018 | 4,083 | 4,083 (0%) | 0% | 0 | Common Stock | |
| Daniel Voytas | Chief Science Officer | Sale of securities on an exchange or to another person at price $ 18.10 per share. | 08 Mar 2018 | 4,083 | 0 (0%) | 0% | 18.1 | 73,914 | Common Stock |
| Daniel Voytas | Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2018 | 4,083 | 44,917 | - | - | Stock Option (Right to Buy) | |
| Alain Godard | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.59 per share. | 05 Mar 2018 | 10,000 | 49,200 (0%) | 0% | 3.6 | 35,878 | Common Stock |
| Alain Godard | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.59 per share. | 05 Mar 2018 | 10,000 | 49,200 (0%) | 0% | 3.6 | 35,875 | Common Stock |
| Alain Godard | None | Sale of securities on an exchange or to another person at price $ 19.00 per share. | 05 Mar 2018 | 10,000 | 39,200 (0%) | 0% | 19 | 190,000 | Common Stock |
| Alain Godard | None | Sale of securities on an exchange or to another person at price $ 19.00 per share. | 05 Mar 2018 | 10,000 | 39,200 (0%) | 0% | 19 | 190,000 | Common Stock |
| Alain Godard | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2018 | 10,000 | 64,300 | - | - | Stock Option (Right to Buy) | |
| Alain Godard | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2018 | 10,000 | 54,300 | - | - | Stock Option (Right to Buy) | |
| Alain Godard | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2018 | 10,000 | 44,300 | - | - | Stock Option (Right to Buy) | |
| Alain Godard | None | Sale of securities on an exchange or to another person at price $ 19.00 per share. | 05 Mar 2018 | 10,000 | 39,200 (0%) | 0% | 19 | 190,000 | Common Stock |
| Alain Godard | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.59 per share. | 05 Mar 2018 | 10,000 | 49,200 (0%) | 0% | 3.6 | 35,875 | Common Stock |
| Michel Arbadji | Director of Business Developme | Sale of securities on an exchange or to another person at price $ 18.63 per share. | 28 Feb 2018 | 3,500 | 29,400 (0%) | 0% | 18.6 | 65,220 | Common Stock |
| Michel Arbadji | Director of Business Developme | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.59 per share. | 28 Feb 2018 | 3,500 | 32,900 (0%) | 0% | 3.6 | 12,557 | Common Stock |
| Michel Arbadji | Director of Business Developme | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2018 | 3,500 | 119,000 | - | - | Stock Option (Right-to-Buy) | |
| Alain Godard | None | Sale of securities on an exchange or to another person at price $ 19.03 per share. | 26 Feb 2018 | 10,000 | 39,200 (0%) | 0% | 19.0 | 190,262 | Common Stock |
| Alain Godard | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 35.59 per share. | 26 Feb 2018 | 10,000 | 49,200 (0%) | 0% | 35.6 | 355,878 | Common Stock |
| Alain Godard | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2018 | 10,000 | 74,300 | - | - | Stock Option (Right-to-Buy) | |
| Alain Godard | None | Sale of securities on an exchange or to another person at price $ 19.19 per share. | 20 Feb 2018 | 13,300 | 39,600 (0%) | 0% | 19.2 | 255,200 | Common Stock |
| Alain Godard | None | Sale of securities on an exchange or to another person at price $ 19.00 per share. | 20 Feb 2018 | 400 | 39,200 (0%) | 0% | 19 | 7,600 | Common Stock |
| Alain Godard | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.71 per share. | 20 Feb 2018 | 6,125 | 45,325 (0%) | 0% | 3.7 | 22,724 | Common Stock |
| Alain Godard | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.58 per share. | 20 Feb 2018 | 13,700 | 52,900 (0%) | 0% | 3.6 | 49,046 | Common Stock |
| Alain Godard | None | Sale of securities on an exchange or to another person at price $ 21.90 per share. | 20 Feb 2018 | 600 | 39,200 (0%) | 0% | 21.9 | 13,140 | Common Stock |
| Alain Godard | None | Sale of securities on an exchange or to another person at price $ 21.23 per share. | 20 Feb 2018 | 1,900 | 39,800 (0%) | 0% | 21.2 | 40,341 | Common Stock |
| Alain Godard | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2018 | 6,125 | 0 | - | - | Stock Option (Right-to-Buy) | |
| Alain Godard | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2018 | 13,700 | 84,300 | - | - | Stock Option (Right-to-Buy) | |
| Alain Godard | None | Sale of securities on an exchange or to another person at price $ 20.23 per share. | 20 Feb 2018 | 3,625 | 41,700 (0%) | 0% | 20.2 | 73,322 | Common Stock |
| Bryan W. J. Corkal | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 20.24 per share. | 20 Feb 2018 | 5,700 | 92,300 (0%) | 0% | 20.2 | 115,347 | Common Stock |
| Bryan W. J. Corkal | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 21.20 per share. | 20 Feb 2018 | 3,000 | 89,300 (0%) | 0% | 21.2 | 63,585 | Common Stock |
| Bryan W. J. Corkal | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 21.88 per share. | 20 Feb 2018 | 1,100 | 88,200 (0%) | 0% | 21.9 | 24,064 | Common Stock |
| Bryan W. J. Corkal | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 20.32 per share. | 20 Feb 2018 | 6,189 | 82,011 (0%) | 0% | 20.3 | 125,730 | Common Stock |
| Bryan W. J. Corkal | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 21.46 per share. | 20 Feb 2018 | 3,611 | 78,400 (0%) | 0% | 21.5 | 77,503 | Common Stock |
| Manoj Sahoo | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 20.22 per share. | 20 Feb 2018 | 2,854 | 95,146 (0%) | 0% | 20.2 | 57,694 | Common Stock |
| Manoj Sahoo | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 21.92 per share. | 20 Feb 2018 | 400 | 93,100 (0%) | 0% | 21.9 | 8,768 | Common Stock |
| Manoj Sahoo | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 19.51 per share. | 20 Feb 2018 | 980 | 92,120 (0%) | 0% | 19.5 | 19,121 | Common Stock |
| Manoj Sahoo | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 19.13 per share. | 20 Feb 2018 | 4,900 | 87,220 (0%) | 0% | 19.1 | 93,730 | Common Stock |
| Manoj Sahoo | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 21.20 per share. | 20 Feb 2018 | 1,646 | 93,500 (0%) | 0% | 21.2 | 34,900 | Common Stock |
| Philippe Dumont | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2017 | 29,400 | 29,400 | - | - | Stock Option (Right to buy) | |
| Philippe Dumont | None | Purchase of securities on an exchange or from another person at price $ 8.00 per share. | 14 Jun 2017 | 400 | 20,000 (0%) | 0% | 8 | 3,200 | Common Stock |
| Philippe Dumont | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2017 | 19,600 | 19,600 (0%) | 0% | 0 | Restricted Stock Unit |